These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 4520399)
61. Physiologic and biochemical basis for the treatment of gout and hyperuricemia. Mikkelsen WM; Robinson WD Med Clin North Am; 1969 Nov; 53(6):1331-47. PubMed ID: 4900718 [No Abstract] [Full Text] [Related]
62. Effects of fatty acids on two specific drug binding sites on human serum albumin. Birkett DJ; Myers SP; Sudlow G Mol Pharmacol; 1977 Nov; 13(6):987-92. PubMed ID: 593269 [No Abstract] [Full Text] [Related]
63. Effect of a phenylbutazone analog (4-[phenylthioethyl]-1, 2-diphenyl 3, 5-pyrazolidinedione) on urate clearance and other discrete renal functions in gouty subjects; evaluation as uricosuric agent. YU TF; PATON BC; CHENKIN T; BURNS JJ; BRODIE BB; GUTMAN AB J Clin Invest; 1956 Apr; 35(4):374-85. PubMed ID: 13306779 [No Abstract] [Full Text] [Related]
64. Renal regulation of uric acid excretion in normal and gouty man; modification by uricosuric agents. GUTMAN AB; YU TF Bull N Y Acad Med; 1958 May; 34(5):287-96. PubMed ID: 13523299 [No Abstract] [Full Text] [Related]
65. Renal excretion of urate in normal and gouty subjects at high, normal and low plasma urate levels. Fontenaille C; Guiheneuc P; Heron B; Prost A; Lucas J Biomedicine; 1974 Sep; 21(9):382-5. PubMed ID: 4457158 [No Abstract] [Full Text] [Related]
66. The binding of urate by plasma proteins. Bertolini J; Masarei JR Aust J Exp Biol Med Sci; 1979 Feb; 57(1):51-60. PubMed ID: 475669 [TBL] [Abstract][Full Text] [Related]
67. Influence of urate-lowering therapies on renal handling of uric acid. Ma L; Wei L; Chen H; Zhang Z; Yu Q; Ji Z; Jiang L Clin Rheumatol; 2016 Jan; 35(1):133-41. PubMed ID: 25373449 [TBL] [Abstract][Full Text] [Related]
68. Uptake of uric acid by separated renal tubules of the rabbit. II. Effects of drugs. Kippen I; Nakata N; Honda S; Klinenberg JR J Pharmacol Exp Ther; 1977 Apr; 201(1):226-32. PubMed ID: 850142 [TBL] [Abstract][Full Text] [Related]
69. Long term uricosuric therapy in gout. THOMPSON GR; DUFF IF; ROBINSON WD; MIKKELSEN WM; GALINDEZ H Arthritis Rheum; 1962 Aug; 5():384-96. PubMed ID: 13920871 [No Abstract] [Full Text] [Related]
71. Pharmacology of pyrazinamide: metabolic and renal function studies related to the mechanism of drug-induced urate retention. Weiner IM; Tinker JP J Pharmacol Exp Ther; 1972 Feb; 180(2):411-34. PubMed ID: 4622054 [No Abstract] [Full Text] [Related]
72. Bidirectional urate transport limited to the proximal tubule in dogs. Zins GR; Weiner IM Am J Physiol; 1968 Aug; 215(2):411-22. PubMed ID: 5665174 [No Abstract] [Full Text] [Related]
73. Renal handling of uric acid in normal and gouty subject: evidence for a 4-component system. Levinson DJ; Sorensen LB Ann Rheum Dis; 1980 Apr; 39(2):173-9. PubMed ID: 7387222 [TBL] [Abstract][Full Text] [Related]
74. Uricosuric effect of radiocontrast agents. A study in man of four commonly used preparations. Postlethwaite AE; Kelley WN Ann Intern Med; 1971 Jun; 74(6):845-52. PubMed ID: 5580635 [No Abstract] [Full Text] [Related]
75. Hyperuricemia: when does it signify gout? Healey LA Med Times; 1972 Nov; 100(11):169-70 passim. PubMed ID: 4639059 [No Abstract] [Full Text] [Related]
76. THE TREATMENT OF GOUT. TREADWELL B N Z Med J; 1964 Sep; 63():567-74. PubMed ID: 14210072 [No Abstract] [Full Text] [Related]
77. Factors affecting the binding of urate to plasma proteins. Bluestone R; Kippen I; Klinenberg JR; Whitehouse WM Ann Rheum Dis; 1970 May; 29(3):330-1. PubMed ID: 5432599 [No Abstract] [Full Text] [Related]
78. Effect of drugs on urate binding to plasma proteins. Bluestone R; Kippen I; Klinenberg JR Br Med J; 1969 Dec; 4(5683):590-3. PubMed ID: 5356547 [TBL] [Abstract][Full Text] [Related]
79. Renal handling of uric acid in man. Levinson DJ; Decker DE; Sorensen LB Ann Clin Lab Sci; 1982; 12(1):73-7. PubMed ID: 7065639 [TBL] [Abstract][Full Text] [Related]
80. Renal excretion and uricosuric properties of halofenate, a hypolipidemic-uricosuric agent, in the chimpanzee. Fanelli GM; Bohn DL; Reilly SS; Baer JE J Pharmacol Exp Ther; 1972 Feb; 180(2):377-96. PubMed ID: 5010680 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]